Latest News for State Affiliates – May 14, 2020

Help spread the word by sharing relevant information from this newsletter with your members.

ASCO Coronavirus Resources

Archived issues of Latest News can be found on myAffiliates

Click within the table of contents to navigate Latest News.

• 2020 State Affiliate Council Election Results • Organizations Urge Congress to Support CLINICAL

TREATMENT Act • Join ASCO in Helping to Understand COVID-19 Impact

on Patients • Tips to Add Sponsor Value to Your Society’s Virtual

Event • ASCO Policy Statement on Skin Cancer Prevention

Table of Contents

2020 State Affiliate Council Election Results Last Friday, May 8, the State Affiliate Council held its virtual spring meeting and election. Thank you to all who participated in and contributed to the great discussions. The election for the State Affiliate Council Executive Subcommittee included candidates for Chair-Elect, Executive Director representative, and Physician representative. Congratulations to our newly-elected leaders, whose 3-year terms begin in June following the virtual ASCO Scientific Meeting:

• Chair-Elect: Dr. Charles Miller (Hawaii) • Executive Director: Tammy Thiel (Alaska) • Physician: Dr. Sakeer Hussain (Iowa)

Thank you to Dr. Rick McDonough (Florida) and Dr. Rahul Seth (New York) for their continued participation in the work of the Council and willingness to serve on the Executive Subcommittee. We also wish to thank Dr. Elizabeth Blanchard, Immediate Past Chair (Massachusetts), Mr. Dave Dillahunt, Executive Director representative (Ohio), and Dr. Rahul Seth for their contributions to the Council’s work and leadership for the past three years. Your volunteer spirit is greatly appreciated. Slide presentations from the State Affiliate Council Meeting are available on myAffiliates. Please contact Aishat Magbade with any questions. Organizations Urge Congress to Support CLINICAL TREATMENT Act The Association for Clinical Oncology (ASCO) recently sent a letter to House and Senate leadership urging their support for policies to increase diversity in clinical trials, including the CLINICAL TREATMENT Act (H.R. 913), in a future COVID-19 response package. These policies were included in Title IV of the Cures 2.0 concept paper, which was developed by Representatives Diana DeGette (D-CO) and Fred Upton (R-MI) to safely and efficiently modernize the delivery of health care in the wake of the coronavirus pandemic. Seventy-seven organizations representing researchers, physicians, survivors, and their families signed onto the letter in support of these provisions. Thank you to the following Affiliates for joining ASCO in support of this effort in such a quick turnaround:

• Alabama Cancer Congress • The Arizona Clinical Oncology Society • Medical Oncology Association of Southern California, Inc. • Rocky Mountain Oncology Society • Delaware Society for Clinical Oncology • Florida Society of Clinical Oncology • Georgia Society of Clinical Oncology

Table of Contents

• Hawaii Society of Clinical Oncology • Illinois Medical Oncology Society • Indiana Oncology Society • Iowa Oncology Society • Kansas Society of Clinical Oncology • Louisiana Oncology Society • Massachusetts Society of Clinical Oncologists • Michigan Society of Hematology and Oncology • Minnesota Society of Clinical Oncology • Mississippi Oncology Society • Missouri Oncology Society • Montana State Oncology Society • Nebraska Oncology Society • Nevada Oncology Society • Empire State Hematology & Oncology Society • North Carolina Oncology Association • Northern New England Clinical Oncology Society • Oklahoma Society of Clinical Oncology • South Carolina Oncology Society • Tennessee Oncology Practice Society • Texas Society of Clinical Oncology • Society of Utah Medical Oncologists • Virginia Association of Hematologists and Oncologists • West Virginia Oncology Society • Wisconsin Association of Hematology and Oncology

Read more on ASCO in Action. Join ASCO in Helping to Understand COVID-19 Impact on Patients The American Society of Clinical Oncology (ASCO) launched the ASCO Survey on COVID-19 in Oncology Registry (ASCO Registry) to help the entire cancer community learn about the pattern of symptoms and severity of COVID-19 among patients with cancer, as well as how COVID-19 infections impact the delivery of cancer care and patient outcomes. The registry will collect both baseline and follow up data throughout the COVID-19 pandemic and into 2021. We invite you to share information about the registry with your members so that ASCO can increase awareness and participation in the registry. During these unprecedented times, we need to ensure that we are learning from every patient, in every practice or hospital across the country so that we can inform care for all of our patients with cancer. Read more on ASCO in Action.

Table of Contents

Tips to Add Sponsor Value to Your Society’s Virtual Event Many events would not be possible without the help and support of sponsors. So, what happens when you are forced to go virtual? This MemberClicks article provides ideas on how to engage sponsors before and during your virtual events. If your society would like to share ideas on how you have been engaging sponsors virtually, please post a message on myAffiliates to keep the conversation going. ASCO Policy Statement on Skin Cancer Prevention The American Society of Clinical Oncology (ASCO) released a new policy statement on skin cancer prevention to affirm ASCO’s support for and commitment to policies aimed at lessening the burden of skin cancer through reducing exposure to UV radiation (UVR) for youth and adults. The recommendations call for reducing exposure to indoor tanning, increased public efforts to promote sun protection, investments to community education and outreach, and highlights the critical role of oncology providers. The recommendations were developed by ASCO’s Skin Cancer Prevention Writing Group under the Cancer Prevention Committee, approved by the Board of Directors, and accepted after peer review for publication in the JCO Oncology Practice.